Nova Eye Medical Ltd (AU:EYE) has released an update.
Nova Eye Medical Limited has announced the issuance of 105,000 new unquoted equity securities, specifically performance rights, under their employee incentive scheme on May 10, 2024. These securities will not be available for trading on the ASX as they are intended for internal company allocations. The move is part of the company’s efforts to incentivize and reward their employees.
For further insights into AU:EYE stock, check out TipRanks’ Stock Analysis page.
Click Here to Read the Full Original Article at TipRanks Financial Blog…
